Monthly Archives April 2007

Beyond Technology: Other Medtech Market Forces

Beyond Technology Innovation:  Future Market Forces and Trends 
The number and variety of technology-based forces that are impacting medical markets now and that will create, overturn, redefine or otherwise have significant effects on patient care and, by extension, medical market success are simply staggering.  There is a dissolution of “traditional” boundaries between devices, drugs and diagnostics, with devices that [...]

Skip the chemo and take an aspirin?

As I was considering topics for the April issue of MedMarkets, I came across a story in Reuters that aspirin was associated with reduced incidence and mortality from cancer.  That aspirin should have such a therapeutic benefit was not surprising, especially considering the data that has been appearing from different sources that inflammation (aspirin is [...]

Medtech Startups, March 2007

From the March 2007 issue of MedMarkets.
New technologies at medtech startups:

Company
Principal(s)
Location
Product/Technology
Founded

Biocross, Inc.
(Finistere Ventures)
Laguna Niguel, CA
Device to enable crossing chronic total occlusions in both peripheral and coronary applications
2006

JenaValve Technology GmbH
Helmut Straubinger, CEO
Munich, Germany
Minimally invasive, self-expanding aortic heart valve
2006

Lotus Medical, LLC
Andrew K. Palmer, MD
San Diego, CA
Compression technology for treatment of non-union fractures
2007

Minimally Invasive Devices, LLC
Undisclosed
Columbus, OH
Devices to [...]